Menu
Search
|

Menu

Close
X

Merck & Co Inc MRK.N (New York Stock Exchange)

81.39 USD
-1.30 (-1.57%)
As of Jul 19
Previous Close 82.69
Open 82.81
Volume 4,493,551
3m Avg Volume 3,389,183
Today’s High 82.81
Today’s Low 81.16
52 Week High 87.07
52 Week Low 62.09
Shares Outstanding (mil) 2,574.65
Market Capitalization (mil) 209,550.30
Forward P/E 24.59
Dividend (Yield %) 0.55 ( 2.70 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.62 Mean rating from 16 analysts

KEY STATS

Revenue (mm, USD)
FY19
10,816
FY18
42,294
FY17
40,122
FY16
39,807
EPS (USD)
FY19
1.146
FY18
2.436
FY17
1.829
FY16
1.403
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
24.59
34.52
Price to Sales (TTM)
vs sector
4.86
7.97
Price to Book (MRQ)
vs sector
7.63
4.45
Price to Cash Flow (TTM)
vs sector
16.18
24.33
Total Debt to Equity (MRQ)
vs sector
94.03
17.60
LT Debt to Equity (MRQ)
vs sector
82.50
12.58
Return on Investment (TTM)
vs sector
13.08
12.69
Return on Equity (TTM)
vs sector
28.61
17.17

EXECUTIVE LEADERSHIP

Kenneth Frazier
Chairman of the Board, President, Chief Executive Officer, Since 2011
Salary: $1,610,580.00
Bonus: $3,061,800.00
Robert Davis
Executive Vice President, Global Services, Chief Financial Officer, Since 2016
Salary: $1,043,730.00
Bonus: $1,389,980.00
Steven Mizell
Executive Vice President, Chief Human Resources Officer, Human Resources, Since 2018
Salary: --
Bonus: --
Jim Scholefield
Executive Vice President, Chief Information and Digital Officer, Since 2018
Salary: --
Bonus: --
Michael Nally
Executive Vice President, Chief Marketing Officer, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2000 Galloping Hill Rd
KENILWORTH   NJ   07033-1310

Phone: +1908.7404000

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

SPONSORED STORIES